Author: Il Bioeconomista

Strong results in Italy for Genomatica’s GENO BDO biobased process technology

Il BioeconomistaLeave a comment
Christophe Schilling, CEO of Genomatica during his speech at the Grand Opening of Mater Biotech’s plant in Bottrighe di Adria, Italy

Genomatica has strong results for its GENO BDO biobased process technology regarding overall process performance and production volume to date for bio-based 1,4-butanediol (BDO). Novamont, Genomatica’s first GENO BDO licensee, has officially confirmed that its new industrial plant in Bottrighe, Italy has met all performance guarantees committed to by Genomatica. The guarantees include technical and economic parameters, such as efficiency of converting feedstock sugars to Bio- BDO product and product quality. The process runs as designed, as modeled, and as represented.

Continue reading →

Arkema will invest some €300 million over 5 years in the biosourced polyamide 11 chain

Il BioeconomistaLeave a comment

Arkema will invest some 300 million euros over five years in the biosourced polyamide 11 chain. This major investment will enable the French chemical group to increase by 50% its polyamide 11 global production capacities. The project falls in line with Arkema’s strategy to speed up its development in advanced materials, one of the key pillars of its future growth, sustained by a unique portfolio of innovations around the main sustainable development trends.

Continue reading →

India is on track to exceed its Paris commitments thanks to LanzaTech

Il BioeconomistaLeave a comment
Jennifer Holmgren, Ceo of Lanzatech

There is a new partnership in the world bioeconomy. Indian Oil Corporation Limited, India’s flagship national oil company and, LanzaTech, carbon recycling company based in Illinois, signed a Statement of Intent to construct the world’s first refinery off gas-to-bioethanol production facility in India.

Continue reading →

The City of Turin goes green thanks the new Eni fuel with a 15% of renewable component

Il BioeconomistaLeave a comment

Italian oil giant Eni, the City of Turin, GTT (Gruppo Torinese Trasporti) and Amiat, an Iren Group company, have signed an agreement to launch a large-scale experimental project with Turin buses using Eni Diesel+, the new Eni fuel with a 15% of renewable component. Under the agreement, the Turin public transport company will pay Eni Diesel+ at the same price as the diesel fuel that its vehicles have used on the urban network up to now. This follows Eni’s success at the tender to supply the fuel for Turin’s buses.

Continue reading →

Danish Asnæs Power Station to phase out coal

Il BioeconomistaLeave a comment
Aerial view of Kalundborg sustainable industry complex

Novozymes, Novo Nordisk, Kalundborg Forsyning and DONG Energy signed a new 20-year agreement which enables Denmark’s largest coal-fired power station unit, the Asnæs Power Station, to phase out coal and replace it with wood chips. Novozymes sources steam from the power station.

Continue reading →

An interview with Jaymin Amin, Chief Operating Officer, Ingenza

Il BioeconomistaLeave a comment
The team of Ingenza

“The UK cannot solve the problem on its own, and we will need to collaborate with foreign governments and companies if we are to truly tackle the crisis ahead.” To say it referring to Brexit – in this exclusive interview with Il Bioeconomista – is Jaymin Amin, COO at Ingenza, the spin-out from the University of Edinburgh founded in 2002, which is today one of the most dynamic European industrial biotech company. With Amin we talk about industrial biotechnology and bioeconomy in Scotland.

Interview by Mario Bonaccorso

Continue reading →

Start-up of Metsä Group’s bioproduct mill to begin next August

Il BioeconomistaLeave a comment
Metsa Group Aanekoski pulp mill. Source: http://www.metsafibre.com

The Metsä Group’s bioproduct mill start-up will begin in mid-August, and pulp deliveries from the new mill to customers will begin in early September. The current pulp mill at Äänekoski – the company announced – will be shut down once the bioproduct mill starts up.

Continue reading →

Amyris’ new specialty farnesene fermentation factory in Queensland takes a step forward

Il BioeconomistaLeave a comment

Queensland Premier Annastacia Palaszczuk
Amyris, the U.S. industrial bioscience company, and the Government of Queensland, Australia, announced the next step their plans to develop a leading industrial biotechnology hub in Southeast Asia. Plans call for developing a new production plant with support from local partners to produce Amyris’s sugar cane-based ingredient called farnesene, which is used in products including cosmetic emollients, fragrances, nutraceuticals, polymers, and lubricants.

Continue reading →

ExxonMobil and Synthetic Genomics achieve algae biofuel breakthrough

Il BioeconomistaLeave a comment

ExxonMobil, the largest publicly traded petroleum and petrochemical enterprise in the world, and Synthetic Genomics Inc., a global leader in the fields of synthetic biology and synthetic genomics, achieved a breakthrough in joint research into advanced biofuels involving the modification of an algae strain that more than doubled its oil content without significantly inhibiting the strain’s growth.

Continue reading →

Catia Bastioli calls for action: “A circular approach to bioeconomy” 

Il BioeconomistaLeave a comment

Catia Bastioli at the Grand Opening of Mater Biotech, 30 September 2016
The European bioeconomy has its own manifesto. Catia Bastioli, CEO of Novamont, makes it available with her publication “A circular approach to bioeconomy” published by Edizioni Ambiente, the leading Italian publisher on environmental issues. This is a real action plan that involves all of us as consumers and, first of all, as citizens and people, starting from the successful case of the company headquartered in Novara and, as Bastioli recalls in the subtitle, offers a great “opportunity to decarbonise the economy and reconnect it with society “.

Continue reading →